Bone regeneration agent patent, Kao Corporation, Mar 25
ChangeBridge: EPO Bulletin - Therapeutics (A61P)
Summary
Bone regeneration agent patent, Kao Corporation, Mar 25
Source document (simplified)
BONE REGENERATION AGENT
Publication EP3632435A1 Kind: A1 Mar 25, 2026
Applicants
Kao Corporation
Inventors
TAKAHASHI, Noritaka, FUJII, Akihiko
IPC Classifications
A61K 31/455 20060101AFI20251223BHEP A23L 33/15 20160101ALI20251223BHEP A61K 8/49 20060101ALI20251223BHEP A61P 1/02 20060101ALI20251223BHEP A61P 19/08 20060101ALI20251223BHEP A61Q 11/00 20060101ALI20251223BHEP A61P 19/02 20060101ALI20251223BHEP A61K 9/00 20060101ALN20251223BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Therapeutics (A61P) publishes new changes.